Document is current
Any future updates will be listed below
-
Authors
Leng, Kun
Rooney, Brendan
McCarthy, Frank
Xia, Wenlong
Rose, Indigo V. L.
Bax, Sophie
Chin, Marcus
Fathi, Saeed
Herrington, Kari A.
Leonetti, Manuel
Kao, Aimee
Fancy, Stephen P. J.
Elias, Joshua E.
Kampmann, Martin
-
Funding
Funding for this research was provided by:
National Institutes of Health (F30 AG066418, R01 AG062359, R01NS097551, T32 NS115706, R01AG057342, R01AG057342, R01NS097551, R01 AG062359)
Chan Zuckerberg Initiative (Early Career Acceleration Award, Early Career Acceleration Award)
California Institute of Regenerative Medicine (EDUC4-12812)
- License Information
-
More Information
Article History
Received: 27 March 2024
Accepted: 3 July 2024
First Online: 8 August 2024
Declarations
:
: Not applicable.
: Not applicable.
: A.W.K is a member of the Scientific Advisory Board for Nine Square Therapeutics, Inc. J.E. is an advisor to Seer, Inc. M. K. has filed a patent application related to CRISPRi and CRISPRa screening (PCT/US15/40449), is a co-scientific founder of Montara Therapeutics and serves on the Scientific Advisory Boards of Alector, Engine Biosciences, Casma Therapeutics, and Cajal Neuroscience, and is an advisor to Modulo Bio and Recursion Therapeutics. None of the other authors declare competing interests.
